Study for usability of cell free DNA in maternal plasma to detect fetal aneuploidy

Study for usability of cell free DNA in maternal plasma to detect fetal aneuploidy - Study for usability of cell free DNA in maternal plasma to detect fetal aneuploidy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035810

Enrollment

Registered

2019-02-08

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal aneuploidy

Interventions

NIPT

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant woman in 10+0~21+6 weeks of gestation and 35 years old or more, or fetal aneuploidy in previous pregnancy, or suggested fetal aneuploidy by other prenatal test

Exclusion criteria

Exclusion criteria: apparent fetal morphological anomaly who cannot visit hospital who won't enter this clinical trial

Design outcomes

Primary

Measure	Time frame
detecting the factors for causing false positive / false negative, or not reportable	—

Countries

Japan

Contacts

Public ContactMasanobu Ogawa

Kyushu University Department of Obstetrics and Gynecology

ogawa.masanobu.604@m.kyushu-u.ac.jp+81-92-642-5395

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026